Comparison of MR Enteroclysis and MRI With Per Oral Contrast Using a 6 % Mannitol Solution. - Full Text View

Comparison of MR Enteroclysis and MRI With Per Oral Contrast Using a 6 % Mannitol Solution.

This study is ongoing, but not recruiting participants.

Sponsored by:	University of Oslo
Information provided by:	University of Oslo
ClinicalTrials.gov Identifier:	NCT00204165

Purpose

The purpose of this study is to compare MRI enteroclysis with MRI of the small bowel with a per oral 6%mannitol solution.Our hypothesis is that the peroral technique preform the same way as MRI Enteroclysis.

Condition	Intervention	Phase
Magnetic Resonance Imaging, Intestine Small, Crohn Disease.	Procedure: MRI of the small bowel	Phase III

Genetics Home Reference related topics:

Crohn disease

MedlinePlus related topics:

Crohn's Disease

ChemIDplus related topics:

Mannitol

U.S. FDA Resources

Study Type:	Interventional
Study Design:	Diagnostic, Randomized, Open Label, Uncontrolled, Crossover Assignment

Official Title:	MRI of the Small Bowel. Comparison of Different Techniques and Contrast.

Further study details as provided by University of Oslo:

Estimated Enrollment:	40
Study Start Date:	November 2004
Estimated Study Completion Date:	June 2005

Eligibility

Ages Eligible for Study:	18 Years and older
Genders Eligible for Study:	Both
Accepts Healthy Volunteers:	No

Criteria

Inclusion Criteria:

above 18 years
known Crohns disease or strong suspicion.
need of a small bowel examination

Exclusion Criteria:

pregnant
electrolyte disturbances.
Any MRI contraindications.

Contacts and Locations

Please refer to this study by its ClinicalTrials.gov identifier: NCT00204165

Locations


Norway, Oslo
	Ulleval Universitets sykehus
	Kirkeveien 166, Oslo, Norway, 0407

Sponsors and Collaborators

University of Oslo

Investigators


Study Director:	Nils-Einar Kløw, Prof. MD	Ulleval Universitetssykehus

More Information

Study ID Numbers:	431-04150
First Received:	September 13, 2005
Last Updated:	September 7, 2006
ClinicalTrials.gov Identifier:	NCT00204165
Health Authority:	Norway: Directorate for Health and Social Affairs

Study placed in the following topic categories:

Digestive System Diseases

Mannitol

Gastrointestinal Diseases

Crohn Disease

Inflammatory Bowel Diseases

Gastroenteritis

Intestinal Diseases

ClinicalTrials.gov processed this record on October 16, 2008